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Summary 
Transgenic mice homozygous for a B2-microglobulin (B2-m) gene disruption and normal mice 
that had been treated with a CD8-specific mAb were infected intranasally with an H3N2 influenza 
A virus. Both groups of CD8 T cell-deficient mice eliminated the virus from the infected respiratory 
tract. Potent CTL activity was detected in lung lavage populations taken from mice with intact 
CD8 + T cell function, with minimal levels of cytotoxicity being found for inflammatory cells 
obtained from the antibody-treated and B2-m mutant mice. We therefore conclude that cells 
infected with an influenza A virus can be cleared from the respiratory tract of mice lacking both 
functional class I major histocompatibility complex (MHC) glycoproteins and class I MHC- 
restricted, CD8 + effector T  cells. 
T 
he CD4-8 + ce/3 T cell is considered to be the primary 
mediator of viral clearance in virus infections (1). The 
central idea is that the class I MHC glycoproteins that present 
the  viral  peptides  recognized by  the  CD8 +  effectors are 
widely expressed (or readily induced) in most tissues,  thus 
minimizing the possibility that infected cells will escape im- 
mune surveillance (2, 3). The immunopathogenesis of mu- 
rine influenza pneumonia is thought to be in general accord 
with this model (4). Potent, influenza-specific class I MHC- 
restricted CTL activity is found in the lung after 7 d of infec- 
tion, with virus clearance being only slightly delayed in mice 
depleted of CD4 + T cells (5). Early elimination of influenza 
virus from naive mice is promoted by the adoptive transfer 
of virus-specific CD8 + effectors,  either as cloned lines or as 
populations of immune spleen cells (4, 6,  7). The immune 
T cells apparently interact directly with lung cells expressing 
surface changes induced by the virus, as mice infected simul- 
taneously with two different influenza A viruses only show 
rapid clearance of the virus for which the transferred, CD8 + 
CTL line is specific (7).  However, the conclusion that the 
CD8 +  T  cell is  the  sole  effector capable  of terminating 
influenza pneumonia has yet to be substantiated. The present 
analysis thus addresses this question using both conventional 
mice depleted of CD8 § effectors by in vivo treatment with 
a CD8-specific mAb (8,  9),  and transgenic mice homozy- 
gous for a 32-microglobulin (32-m) 1 gene disruption (32-m 
1  Abbreviations used in thispaper: 32-m (-/-)  or (+/-), 32-microglobulin 
homozygous or heterozygous for gene disruption; MLN, mediastinal lymph 
node. 
[-/-])  that lack functional class I MHC glycoproteins and 
CD8 + &B T  cells  (10). 
Materials and Methods 
Mice.  Female  C57B1/6J (B6, H-2  b) mice purchased from The 
Jackson Laboratory (Bar Harbor, ME) were infected at 8 wk of 
age. Mice transgenic for a homozygous (-/-)/32-m gene disrup- 
tion, and heterozygous (+/-) controls that express class I MHC 
glycoproteins normally, were derived from (129  x  B6)F2 (H-2  ~) 
founder stock (10). They were bred at the Whitehead Institute, 
and later transferred to St. Jude Children's Research Hospital. Apart 
from the influenza infection, mice were maintained under specific 
pathogen-free conditions. 
Viruses.  The A/HKx31 (H3N2) influenza A virus (11) was 
grown in the allantoic cavity of embryonated chicken eggs. Stocks 
of allantoic fluid containing  this virus were shown to be free of 
bacteria, including mycoplasma, and endotoxin (5). The mice were 
infected  intranasally  under  Avertin  (2,2,2-tribromoethanol) 
anesthesia with 30/zl of PBS containing 240 hemagglutinating units 
of the virus, which represents ~1/10 of the lethal inoculum for 
8-wk, female B6 mice (our unpublished data). Virus was re-isolated 
from the experimental mice by grinding the lungs in 1.0 ml of 
PBS, then injecting 200 #1 of serial 10-fold dilutions into the allan- 
toic cavity of embryonated chicken eggs. Samples of allantoic fluid 
were tested 48 h later for hemagglutinating activity, and the results 
were reported as the antilog of the dilution at which virus was 
detected in 50%  of the eggs inoculated (12). 
Depletion ofCD8 + T  Cells.  Mice were depleted of CD8 + T 
cells by intraperitoneal inoculation with 0.5-ml aliquots of a 1:10 
dilution of mouse ascitic fluid containing the 2.43.1 mAb (9). The 
mAb was given 3 d before, on the day of infection, at 3 d after, 
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titer of the undiluted ascites was 1:5,000, as determined by flow 
cytometry after incubation of 150  /zl of ascitic fluid with 106 
thymocytes (5). 
Inflammatory  Cells and  Lymphocyte Phenotyping.  Cells were 
lavaged from the lungs of 4-10 anesthetized, virus-infected mice 
as described previously (5). The pooled lung lavage populations 
were washed, counted, and adhered on plastic for 90 min at 37~ 
to remove  macrophages. The lymphocytes were then processed for 
flow cytometric analysis  using a FACScan  |  (Becton Dickinson & 
Co., Mountain View, CA) in single-color or two-color mode. The 
mAbs used for staining were 2Cll anti-CD3 (13), H57.597 anti- 
ot/B TCR (14), GL3 anti-3,/~ TCR (15), H129.19 anti-CD4 (16), 
31M anti-CD8ct (9), and 53-5.8 anti-CDf/3  (FITC-conjugated; 
Pharmingen, San Diego, CA). The first three mAbs were derived 
from hamsters, while the remainder are of rat origin. The FITC- 
conjugated second-step reagents for the single-color analysis  were 
goat anti-hamster lg (Southern Biotechnology,  Birmingham, AL) 
and mouse anti-rat Ig (Jackson Immunoresearch,  West Grove, PA). 
Binding of the mAbs to CD8 is not blocked by the 2.43.1 mAb 
used for the in vivo depletions. 
Cytotoxicity Assays.  Lung lavage cells were pooled from 4-10 
mice, depleted of macrophages, and tested directly for the presence 
of  cytotoxic T cells. Lymph node cells  were first stimulated in vitro 
with a syngeneic, virus-infected alveolar macrophage cell line (17) 
or splenocytes. Influenza-specific  effectors  were assayed  on MHC- 
compatible,  SlCr-labeled, A/HKx31-infected,  MC57G  (H-2  b) 
fibroblasts (5)  or LB15.13 hybridoma cells (I-A  d/b, bEd/b). The 
former target detects class I MHC-restricted effectors, while the 
latter is lysed by both class I and class II MHC-restricted popula- 
tions. NK cell activity was measured on the YAC-1 target (18). 
Normal MC57G or P815 cells were used as targets in the presence 
of 0.01% PHA lectin (Difco Laboratories, Detroit,  MI) to detect 
any cells with activated lytic machinery. P815 cells with an FcR- 
bound mAb to CD3e (13) were used to demonstrate the presence 
of CD3 + cytotoxic effectors. The levels of cytotoxicity are ex- 
pressed as percent specific SlCr release in a 6-h assay (5). 
Results 
In  Vivo Depletion  with a CD8-specific  rnAb~  Elimination 
of the CD8 § T  cells (CD8c~ and CD8~;  Table 1) neither 
greatly modified the severity of the inflammatory  process nor 
prevented virus clearance (Table I). The cellular response during 
infection in normal mice was progressively dominated by the 
CD8 + cx/~ T  cells, with the CD8/CD4 ratios in the lung 
lavage populations ranging from 2.5:1 on day 5 to >6:1 on 
day 7. The CD8-depleted mice showed a relative increase in 
the prevalence of the CD4 § subset (Table 1), with the total 
numbers  of CD4 + lymphocytes increasing approximately 
threefold (compared to untreated mice) by 10 d after infec- 
tion. The numbers of 3//6 T  cells were also about twofold 
higher in mice lacking the CD8 + subset.  However, we do 
not  know  how  accurate  a  reflection the  flow cytometry 
findings are of the total numbers of 3'/~ T cells in the lung: 
recent experiments (our unpublished data) have shown that 
many cells that express 3'/6 TCK mKNA (19) are in a set 
with high 90 ~ light scatter, which stains nonspecifically and 
is normally gated out on the flow cytometer. 
As might be expected, dimination of the CD8 + T  ceils 
prevented the development of virus-specific  class I  MHC- 
restricted CTL (Table 2). Activation of NK cells, a normal 
feature of the early response to many infectious viruses (18), 
was not prolonged in the CD8-depleted mice (YAC-1 target; 
Table 2).  Similarly,  the absence  of the CD8 § o~/~ T  calls 
throughout the course of the disease process did not facili- 
tate  the  emergence  of other  cytotoxic effectors,  such  as 
Table  1.  Effect of In  Vivo Depletion of CD8 + T  Cells on  Virus Clearance and T  Cell Localization to the Lung 
Lung lavage populations 
Days  Virus  Percent cells staining 
after  titer  Cell count/ 
Group  infection  in lung  mouse  Control  CD8cr  CD8/~  CD4  CD3  c~//3  y/t~ 
Untreated 
CD8- 
depleted 
x  10  s 
5  >6.0  8  3  32  28  13  70  63  13 
7  3.5  26  1  53  57  10  87  80  4 
10  0  19  1  67  65  10  93  91  6 
13  0  11  1  56  55  16  89  82  7 
5  >6.0  10  2  3  1  19  56  41  20 
7  >6.0  20  2  3  2  20  50  44  10 
10  0  15  2  2  2  41  77  51  13 
13  0  11  1  4  2  38  78  61  12 
Normal B6 mice and mice depleted of CD8 + T cells with the 2.43.1 mAb were infected  intranasally  with the A/HKx31 virus, (9). The protocols 
for the in vivo T cell depletion, virus titration, and single-color  flow  cytometry  with noncompeting  mAbs are all described in Materials  and Methods. 
The control for the flow cytometric  analysis  was the second antibody alone. 
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CTL and NK Cell Activity in Freshly Isolated Lung 
Lavage Populations 
Percent  specific  sick  release 
(E/T  20:1) 
MC57G  target 
Days after 
infection  Group  With  virus  Without  virus  YAC-1 
8  Untreated  19.2  0.1  6.0 
6  CD8-  3.0  2.6  18.8 
8  depleted  4.5  0  4.7 
10  1.0  0  2.9 
Pooled lung lavage  cells from normal and CDS-depleted  A/HKx31-infected 
B6  mice  were  tested  in  a  6-h  slCr  release assay using  syngeneic 
A/HKx31-infected  and normal MC57G targets and the YAC-1 NK cell 
target,  as described in Materials and Methods. 
CD4 § CTL, lymphokine-activated killer cells, or cytotoxic 
macrophages that could mediate lectin-dependent lysis of P815 
target cells (Table 3). The only cytotoxic activity, specific or 
nonspecific, found for freshly isolated cells was in the lung- 
lavage populations from influenza-infected mice with intact 
CD8 § T  cell function.  Lymphocytes taken directly from the 
regional, mediastinal lymph nodes (MLN) of either the un- 
treated or the CD8-depleted mice were not cytotoxic (Table 
3). However, the presence of CTL precursors in MLN from 
Table  3.  Lectin-dependent  Cytotoxicity  for Lymph Node and 
Lung Cells  from Normal and CD8-depleted  Mice with Influenza 
Percent  specific SlCr release 
Anti-CD8 
Untreated  treated 
In vitro  E/T 
Source  culture  ratio  day 8  day 8  day 10 
Lung  Nil  50:1  38  1  3 
MLN  Nil  50:1  1  0  0 
5 d  20:1  42  0  2 
Some of the A/HKx31-infected  B6 mice were treated with the 2.43.1 
mAb, and freshly isolated MLN and lung cells were tested for lectin- 
dependent cytotoxicity in a 6-h SlCr release assay. These procedures are 
described in Materials and Methods. Other cells were cultured for 5 d 
with an irradiated, influenza-virus infected, class II MHC-positive mac- 
rophage cell line of B6 origin in the absence of added IL-2. 
the normal (but not the CD8-depleted)  mice was shown by 
culturing for 5 d in the presence of a virus-infected B6 mac- 
rophage  line  (Table 3). 
Thus, the development of both CTL in vivo, and precursors 
that  could be expanded  in  vitro  to mediate class  I  MHC- 
restricted, virus-specific cytotoxicity, was essentially limited 
to mice with intact  CD8 §  T  cell function.  The results es- 
tablish  that  influenza  virus is cleared effectively in  the  ab- 
sence of a substantial population  of CD8 + effectors. How- 
ever,  the possibility that a few virus-specific CD8 §  ot/B T 
Table  4.  Virus Clearance and Cytotoxicity in Homozygous (-/-)  ~rm Mutant Mice and Hem Heterozygote  (+/-) Control Mice 
Percent specific SlCr release* 
Days  Virus 
after  isolation  E/T  P815 +  P815 +  Normal 
infection  Group  from lung  ratio  o~CD3  PHA  P185  YAC-1 
10  +/-  0/4  40:1  47  45  3  7 
20:1  44  37  0  7 
-/-  1/4'  40:1  9  2  0  0 
20:1  7  0  0  0 
13  +/-  0/4  20:1  19  31  2  7 
10:1  13  30  1  5 
-/-  0/4  40:1  15  8  1  1 
20:1  7  2  0  0 
The mice were infected intranasally with 240 hemagglutinating  units of the HKx31 influenza A virus. During the course of the experiment, two 
of the homozygotes, and one of the controls, died within 16d of infection. Three remaining fl2-m (-/-)  mice were surviving 30 d post-infection. 
The MLN were tested by two-color flow cytometric analysis for the presence of CD8 + ct/fl TCR § lymphocytes, with none being found in the/~2-m 
( -/-)  mice. 
* The results are for lung lavage cells pooled from four mice. No evidence of cytotoxicity was found for cells from the MLN.  The assay systems 
are described in Materials and Methods. 
* Virus was detected only in an undiluted lung homogenate of one mouse. 
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Influenza-infected  B6 Splenocytes 
Percent of cells 
Percent specific SlCr release (40:1) 
LB15.13  LB15.13  MC57G  P815 
Group  CD8 § or/3 +  CD4 + ot/~ +  With virus  Without virus  With virus  With CD3  YAC-1 
+/-  29.6  51.6  33  0  41  57  0 
-/-  0.8  70.0  22  5  5  33  0 
MLN were obtained from mice infected with A/HKx31 13 d previously. No evidence  of cytotoxicity  was found for cells tested before in vitro culture. 
Cells were stimulated with A/HKx31-infected  B6 splenocytes for 4 d before assay of cytotoxicity using class I MHC + MC57G and class I and II 
MHC § LB15.13 cells as targets. The percent of cells was assessed by two-color flow cytometry. 
cells have escaped the mAb-depletion regime is difficult to 
exclude with  this experimental  system. 
Influenza Infection in  ~2-m (-/-)  Mutant  Mice.  The 
32-m (-/-)  mice lack both CD8 + or~3 T  cells and class I 
MHC glycoproteins (10).  Consequently,  it does not  seem 
possible that  classical  class I MHC restriction  (1,  2) could 
be operating.  Influenza virus was substantially cleared from 
the lungs of both the 32-m (-/-)  mice and the (+/-)  con- 
trois  within  10 d  of infection,  and completely eliminated 
within a further 3 d (Table 4). Potent CTL activity mediated 
by CD3 + lymphocytes was present in the lung lavage cells 
obtained from the (+/-) mice at day 10 after infection, with 
much lower levels of CD3-dependent  (or PHA-dependent) 
cytotoxicity being observed for inflammatory cells from the 
32-m (-/-)  mutants (Table 4). The latter activity could be 
due to CD4 + or~3 T  cells  or 3,/~t T  cells.  Also, there was 
no indication that the NK response measured on YAC-1 cells 
was compensating for the lack of the CD8 + CTL (Table 4). 
Lymph node cells taken from both the 32-m (+/-)  and 
the (-/-)  mice at  13 d  after infection were stimulated in 
vitro with virus-infected splenocytes and assayed 4 d later. 
No evidence for the development of CD8 + ot//3 T cells was 
found for the cultures from the (-/-)  mice, though effectors 
lyric for the class II MHC + LB15.13 targets infected with 
the HK ￿  31 virus were detected (Table 5). Cultures from the 
(+/-)  controls contained a predominance of CD8 + ot/3 T 
cells,  showed strong class  I  MHC-restricted,  virus-specific 
CTL activity, and a higher level of CD3-dependent lysis than 
that observed for the (-/-)  mice lacking the CD8 + popu- 
lation.  Thus,  while virus-specific, class  II MHC-restricted 
CTL can be generated in vitro from the ~2-m (-/-)  mice, 
the overall level of cytotoxic effector function is lower than 
that  found for the  (+/-)  controls. 
Discussion 
The present experiments show that mice lacking functional 
class  I  MHC  glycoproteins  and/or  CD8 +  class  I  MHC- 
restricted effector T cells can eliminate influenza virus from 
the  murine  lung.  The  role  of CD4 +  T  cells  in  murine 
influenza pneumonia has been explored previously by trans- 
ferring immune effectors into native, virus-infected mice: bulk 
populations  of  CD4+8 -  T  cells  isolated  directly  from 
spleens of virus-primed mice did not clear influenza virus (4), 
and even caused enhanced immunopathology, while in vitro 
cultured  virus-specific  CD4+8 -  T  cell  clones  promoted 
rapid recovery (20, 21). Also, removing the CD4 + popula- 
tion by in vivo treatment with mAbs caused little delay in 
virus clearance,  though the virus-specific IgG response was 
greatly diminished (5, 22). The overall condusion is that this 
infection  can  be  terminated  by  either  CD4 +  or  CD8 + 
effectors, but simultaneous removal of both these T cell subsets 
leads to death (our unpublished data). However, the response 
may normally be skewed (4) to emphasize the development 
of CD8 §  T  cell-mediated  immunity. 
The fact that elimination of the CD4 + and CD8 + T  cell 
subsets by in vivo treatment  with mAbs is lethal for mice 
with  influenza  (our  unpublished  data)  indicates  that 
CD4-8-  3'/~ T cells acting alone cannot compensate for the 
absence of the CD4 + and CD8 + effectors. Cells expressing 
y/~ TCK mR.NA are prominent late in the course of influenza 
pneumonia,  but the frequency of lymphocytes that express 
a functional y/5 TCK within  this population  has not yet 
been established (19). It is clear that the majority of the "y/6 
TCR mlLNA + cells found in the lungs of normal mice with 
influenza  are  CD4-8-,  ot/[3 TCR-,  and  are  not  phago- 
cytic (19, 23). Uninfected 32-m (-/-)  transgenic mice show 
normal numbers of 3//5 T cells (10), and there is no evidence 
that these lymphocytes are functionally defective. However, 
whether or not the "y/~ T  ceils play any role in virus clear- 
ance is yet to be established. 
Cells from the 32-m (-/-)  mice do express low concen- 
tration of cell surface H-2D  b glycoprotein, and in the pres- 
ence of exogenous bovine ~2-m, act to some extent as targets 
for alloreactive CTL  specific  for H-2D  b (10).  The  H-2D  b 
molecule presents the influenza virus nucleoprotein peptide 
recognized by most of the CD8 + T  ceils generated during 
the response to this virus in H-2  b mice (3). The inability to 
generate class I MHC-restricted CTL activity in B6 mice in- 
fected with an influenza A virus establishes again (10) that, 
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ecule is nonfunctional in vivo. 
This study establishes that, while class I MHC-restricted 
CD8 + CTL may be the main mediators of influenza virus 
dearance in normal mice (1, 4, 6,  7), an alternative mecha- 
nism exists for terminating the infectious process. The likely 
effector is the virus-specific, class II MHC-restricted, CD4 + 
T  cell  (20,  21). These CD4 + T  calls could mediate virus 
clearance by various mechanisms, such as promoting the local 
influenza-specific B cell response (21), acting directly on class 
II  MHC +  target  cells  in  the  virus-infected  lung,  or 
providing help for other potential effectors such as the 3'//5 
T  cells. The results indicate a redundancy in cell-mediated 
effector mechanisms, at least in young, healthy adult mice 
infected with a virus that grows mainly in surface epithelium. 
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